Early research (Phase 1)UnknownNCT05182567What this trial is testingGLS-5310 Vaccine in Healthy Volunteers as a Booster for SARS-CoV-2 (COVID-19)Who this might be right forCOVID-19Healthy GeneOne Life Science, Inc. 69
Testing effectiveness (Phase 2)UnknownNCT05930730What this trial is testingImmunogenicity and Safety of Comvigen (Bivalent) VaccineWho this might be right forSafety of a Single Dose of COMVIGEN VaccineReactogenicity of a Single Dose of COMVIGEN VaccineImmunogenicity of a Single Dose of COMVIGEN Vaccine+3 more Chulalongkorn University 450
Early research (Phase 1)Not Yet RecruitingNCT07703475What this trial is testingA Safety, Reactogenicity and Immunogenicity Trial of RVX-sCPD9 Booster Intranasal COVID-19 VaccineWho this might be right forCOVID -19 National Institute of Allergy and Infectious Diseases (NIAID) 80
Large-scale testing (Phase 3)WithdrawnNCT06567457What this trial is testingImmunogenicity and Safety Study of Monovalent Omicron XBB.1.5 Vaccine as a Booster in AdultsWho this might be right forCOVID-19 Clover Biopharmaceuticals AUS Pty
Early research (Phase 1)Looking for participantsNCT06821100What this trial is testingThymalfasin (Thymosin Alpha 1; Ta1) as an Enhancer of Vaccine Response Among Older Adults Receiving Booster Doses of COVID-19 VaccineWho this might be right forVaccine ResponseCOVID-19 VaccineImmune Response to Covid 19 Vaccination The Methodist Hospital Research Institute 75